Evidence map›Paper›PMID 35159175›Full record

ReviewCells2022

The Role of the Lysosomal Cl

Giovanni Zifarelli

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A large-scale evolutionary and structural analysis of CLC channels and transporters.Protein science : a publication of the Protein Society · 2025
    Article
  5. Article
  6. Article
  7. CLC gene family inFrontiers in plant science · 2025
    Article
  8. Review
  9. Review
  10. Structural basis of pH-dependent activation in a CLC transporter.Nature structural & molecular biology · 2024
    Article
  11. Article
  12. Metabolomics study of osteopetrosis caused byFrontiers in endocrinology · 2024
    Article
  13. Article
  14. Unveiling the impact of lysosomal ion channels: balancing ion signaling and disease pathogenesis.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Review
  15. Advances in Drug Discovery Targeting Lysosomal Membrane Proteins.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Giovanni ZifarelliInstitute of Biophysics-CNR, 16149 Genova, Italy.
Institute of Genetics and Biophysics · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CLC proteins comprise Cl

Indexed as

Bone ResorptionChloride ChannelsLysosomal Storage DiseasesOsteopetrosisAntiportersHumansLysosomesAntiportersChloride ChannelsCLCN7 protein, humanbonechloride transportlysosomal storage diseaselysosomeorganellar transporterosteoclastosteopetrosisproton transport

Identifiers

PMID35159175
PMCPMC8833911
OpenAlexW4205147894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.